Creating new cell therapies for lung diseases using AI technology

Who could benefit from this research

What this research studies

This research focuses on developing innovative cell therapies to treat idiopathic pulmonary fibrosis (IPF), a severe lung disease that leads to scarring and lung failure. The approach involves using artificial intelligence to identify effective chemical methods for reprogramming easily obtained skin cells into specialized lung cells. By leveraging AI and machine learning, the project aims to streamline the process of generating the necessary cells for therapy, potentially improving treatment options for patients with IPF. The research builds on previous findings that suggest cell replacement therapy could restore lung function in affected individuals.

Why it matters

Where this research is happening

• Cellforma, INC
  Boston, United States Active

Researchers

• Principal investigator: Ietswaart, Jaldert Hugo Rigobert — Cellforma, INC
• Study coordinator: Ietswaart, Jaldert Hugo Rigobert

Related research

Other NIH-funded projects on the same topics.

• Clinical readiness for rare lung diseases (RLDC)

  A group at the University of Cincinnati is building a program to speed up care for people with rare lung diseases by tracking patients over time, improving tests and treatments, and sharing information with patients and clinicians.

  NIH research University of Cincinnati · Cincinnati, United States · NIH-11453391

• Epithelial cells trigger fibroblast activation in lung fibrosis through CTHRC1-TGFb signaling

  A clinician-scientist at Duke is studying how lung lining cells may turn normal fibroblasts into fibrosis-causing cells, aiming to uncover new targets for treatment of diseases like BO and IPF.

  NIH research Duke University · Durham, United States · NIH-11415775

• Molecular origins of chronic lung diseases in the human lung

  Researchers are mapping the tiny cell neighborhoods in diseased lungs to find early clues that could protect or restore normal lung function.

  NIH research Vanderbilt University Medical Center · Nashville, United States · NIH-11415568

• How lung cells and their surroundings drive fibrosis in interstitial lung diseases

  A study to understand how airway cells, surrounding tissue, and their environment contribute to progressive scarring in interstitial lung diseases.

  NIH research University of California Los Angeles · Los Angeles, United States · NIH-11412613

• Loss of Cilia Maintenance in Acquired and Genetic Lung Diseases

  Researchers are studying why tiny hair-like structures in the lungs lose their maintenance and how this affects people with asthma, COPD, and related airway diseases.

  NIH research Washington University · Saint Louis, United States · NIH-11400358

• CMKLR1-targeted imaging to map lung inflammation in ALI and fibrotic lung diseases

  A study to test a new PET imaging tool that targets CMKLR1 to visualize lung inflammation and help predict and monitor disease progression in patients with acute lung injury and fibrotic lung diseases.

  NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11399810

About this research

1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.